share

7,8,9,10,10A,11-Hexahydro-3-Nitro-13H-Pyrido[1',2':3,4]Imidazo[2,1-B]Quinazolin-13-One CAS NO 33852-24-3


Unit Price:

CAS No.:33852-24-3

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

7,8,9,10,10A,11-Hexahydro-3-Nitro-13H-Pyrido[1',2':3,4]Imidazo[2,1-B]Quinazolin-13-One is a high-purity, complex heterocyclic organic compound with a nitro-substituted fused ring system. This specialized chemical serves as a critical advanced pharmaceutical intermediate and a versatile scaffold in modern organic synthesis. It is primarily required by research institutions and pharmaceutical R&D departments for the development of novel active pharmaceutical ingredients (APIs).

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates, particularly those targeting central nervous system (CNS) disorders.
  • Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
  • Organic Synthesis Reagent: Employed in the construction of complex polycyclic nitrogen-containing heterocycles due to its unique fused ring structure.
  • Biochemical Research: Potential use as a precursor or inhibitor in biochemical pathway studies and enzyme targeting.
  • High-Purity Reference Standard: Supplied as a certified reference material for analytical method development and quality control in pharmaceutical manufacturing.

Basic Information

Product Name 7,8,9,10,10A,11-Hexahydro-3-Nitro-13H-Pyrido[1',2':3,4]Imidazo[2,1-B]Quinazolin-13-One
CAS No. 33852-24-3
Molecular Formula C₁₄H₁₂N₄O₃
Molecular Weight 284.27 g/mol
Synonyms 3-Nitro-7,8,9,10,10a,11-hexahydro-13H-pyrido[1',2':3,4]imidazo[2,1-b]quinazolin-13-one; 13H-Pyrido[1',2':3,4]imidazo[2,1-b]quinazolin-13-one, 7,8,9,10,10a,11-hexahydro-3-nitro-; 3-Nitrohexahydropyridoimidazoquinazolinone; CAS 33852-24-3; Nitro-substituted pyridoimidazoquinazolinone; Fused tricyclic nitro compound; Advanced nitrogen heterocycle intermediate.
EINECS Contact for details

Quality Control

Our production of 7,8,9,10,10A,11-Hexahydro-3-Nitro-13H-Pyrido[1',2':3,4]Imidazo[2,1-B]Quinazolin-13-One adheres to stringent quality protocols to ensure batch-to-batch consistency and high purity for research and development applications. All materials are characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your regulatory and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a dry environment and away from direct light exposure to maintain stability and purity.

Specification

Item Specification
Appearance Yellow to light brown crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%
Single Unknown Impurity (HPLC) ≤ 0.5%
Total Impurities (HPLC) ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.